Investor Alert

New York Markets Close in:

Company Close Updates Archives | Email alerts

May 18, 2021, 5:01 p.m. EDT

Inovio Pharmaceuticals Inc. stock outperforms competitors on strong trading day

Watchlist Relevance

Want to see how this story relates to your watchlist?

Just add items to create a watchlist now:

or Cancel Already have a watchlist? Log In

MarketWatch Automation

Shares of Inovio Pharmaceuticals Inc. INO rose 4.56% to $7.11 Tuesday, on what proved to be an all-around dismal trading session for the stock market, with the NASDAQ Composite Index COMP falling 0.56% to 13,303.64 and Dow Jones Industrial Average DJIA falling 0.78% to 34,060.66. This was the stock's third consecutive day of gains. Inovio Pharmaceuticals Inc. closed $26.68 short of its 52-week high ($33.79), which the company reached on June 26th.

The stock outperformed some of its competitors Tuesday, as AbbVie Inc. ABBV rose 0.27% to $117.21, Amgen Inc. AMGN fell 0.60% to $250.86, and AstraZeneca PLC ADR AZN rose 0.20% to $55.99. Trading volume (7.2 M) remained 2.3 million below its 50-day average volume of 9.5 M.

Editor's Note: This story was auto-generated by Automated Insights, an automation technology provider, using data from Dow Jones and FactSet. See our market data terms of use.

Get news alerts on Inovio Pharmaceuticals Inc. — or create your own.
This Story has 0 Comments
Be the first to comment
More News In

Story Conversation

Commenting FAQs »

Partner Center

Link to MarketWatch's Slice.